Product Datasheet
www.leinco.com
excellence in early discovery research       



Recombinant Human Death Receptor 6 (DR6)
Purified No Carrier Protein
(TNFRSF21, BM-018, MGC31965)
Share |

Size


Prod. No.:D332
SourceSf 21 Insect Cells
Pkg. Size:100 µg
Storage:-20°C to -70°C Detailed storage instructions below.
Description
Background:
Death receptor-6 (DR6), also known as TNFRSF21, is a type I transmembrane protein and member of the death domain-containing TNFR superfamily. DR6 is expressed in most human tissues and the highest levels were detected in heart, brain, placenta, pancreas, thymus, lymph node and several non-lymphoid cancer cell lines. It functions as a regulatory receptor for mediating CD4(+) T cell activation and maintaining proper immune responses (1). DR6 interacts with the adaptor protein TRADD and mediates signal transduction through its death domain, and expression of DR6 in mammalian cells induces activation of both NF-κB and JNK and cell apoptosis (2). In addition, DR6 is uniquely cleaved from the cell surface of tumor cell lines by MMP-14, which is associated with tumor malignancy. The ligand for DR6 has not been identified.

Source
Sf 21 Insect Cells
Molecular Weight
The predicted molecular weight of Recombinant Human DR6/TNFRSF21 is Mr 60.3 kDa (monomer). However, the actual molecular weight as observed by migration on SDS Page is Mr 65-75 kDa.
State of Matter
Lyophilized
Formulation
This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives.
Purity
>95% by SDS-PAGE and analyzed by silver stain.
Storage and Stability
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
Endotoxin
<1.0 EU/µg as determined by the LAL method
Amino Acid Sequence
qpeqkasnl igtyrhvdra tgqvltcdkc pagtyvsehc tntslrvcss cpvgtftrhe ngiekchdcs qpcpwpmiek lpcaaltdre ctcppgmfqs natcaphtvc pvgwgvrkkg tetedvrckq cargtfsdvp ssvmkckayt dclsqnlvvi kpgtketdnv cgtlpsfsss tspspgtaif prpehmethe vpsstyvpkg mnstesnssa svrpkvlssi qegtvpdnts sargkedvnk tlpnlqvvnh qqgphhrhil kllpsmeatg geksstpikg pkrghprqnl hkhfdinehl diegrmdpks cdkthtcppc papellggps vflfppkpkd tlmisrtpev tcvvvdvshe dpevkfnwyv dgvevhnakt kpreeqynst yrvvsvltvl hqdwlngkey kckvsnkalp apiektiska kgqprepqvy tlppsrdelt knqvsltclv kgfypsdiav ewesngqpen nykttppvld sdgsfflysk ltvdksrwqq gnvfscsvmh ealhnhytqk slslspgk



Country of Origin
USA
References
1. Na, S. et al. (2006) Immunol. Lett. 106:42
2. Huang, Y. et al. (2004) Curr. Cancer Drug Targets 4:97
Related Products
Anti-Human DR6 (NT) (Leinco Prod. No.: D254)
Recombinant Human DR6 (Leinco Prod. No.: D334)
Anti-Human DR6 (Leinco Prod. No.: D348)
Anti-Human DR6-Biotin ( Antigen Aff. Pur. ) (Leinco Prod. No.: D363)
DR6 (NT) Blocking Peptide (Leinco Prod. No.: D280)
Anti-human DR6 ( Antigen Aff. Pur. ) (Leinco Prod. No.: D375)
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
359 Consort Drive | St. Louis, MO 63011 | (800) 538-1145 | (636) 527-5545 fax
800.538.1145 ® Copyright Leinco Technologies, Inc. 2006 – 2013